Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by BirchBrookon May 19, 2020 8:15pm
346 Views
Post# 31049044

News !!!

News !!!Micron Waste Enters into Definitive Agreement with Covid Technologies Inc. VANCOUVER, May 19, 2020 /CNW/ - Micron Waste Technologies Inc. ("Micron" or the "Company") (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2, OTCQB"MICWF"), is pleased to announce that it has entered into a Definitive Purchase Agreement with the shareholders of Covid Technologies Inc. ("Covid") for the acquisition of all of the shares of Covid. Since announcing the interim agreement with Covid on April 20, 2020, the Company has been completing diligence on Covid, the personal protection equipment ("PPE") industry and anticipated demand for PPE. The Company is of the view that the demand for PPE will increase in the future as Canadian and worldwide economies, education and securities re-open. The anticipated demand for PPE the Company believes will transcend the current need arising from the pandemic and will become a requirement of the "new normal". Covid has established manufacturing capacity through the acquisition of state-of-the-art mask making equipment, including the purchase of a FLK120 surgical mask making machine and over 5 tonnes of raw material for mask production. Covid has additional cash and manufacturing assets having a replacement value of approximately $500,000. Since the interim agreement, Covid has entered into purchase agreements for approximately 1 million masks to private enterprise. Following closing of the purchase and sale, Covid will relocate its manufacturing facilities to the Delta, BC facilities of Micron and be managed by the existing Micron team, together with Covid founder Harveer Sidhu. Micron will continue the research and development of its Cannavore, Pharmavore and Organivore waste digesters from its Delta facilities. In particular, the Pharmavore digestor is anticipated to enter testing and trials with an industry partner in Q2 2020. The Company has in excess of $3M to allocate to its waste digestor business and it is anticipated that the PPE business line will be self-financing based on anticipated sales. Closing of the acquisition is anticipated to be completed by the end of May 2020. About COVID www.covidtechnologies.com In this time of crisis, Covid is preparing to deliver needed PPE by providing Canadian-made, high quality, vapour barrier technology (masks, protective garments), protecting them from biological hazards, pathogens, and superbugs. COVID will begin production of: Class 1 Protective 3ply Surgical masks equipment ASTM F2100 or F2101 guidelines. N95 Reporters About Micron Waste Technologies Inc. Micron is a well-funded industrial/technology company with a manufacturing facility based in Delta, BC. It is developing waste digesters using proprietary technology. Its waste digester business is focused on the cannabis and food industry with its Cannivore, Organivore and Pharmavore waste digesters. The Company will continue its research and development of its waste digester business alongside its PPE manufacturing business. Micron is a public company with listings on the CSE: MWM, OTC: MICWF, and in Frankfurt: 7FM2. Please visit www.micronwaste.com for further information. Kal Malhi Chairman The Canadian Stock Exchange does not ac
Bullboard Posts